Pulmonary Drug Delivery by Surfactant

Pulmonary Drug Delivery by Surfactant

Saved in:

Bibliographic Details
Main Author:	Po-Nien Tsao
Format:	Article
Language:	English
Published:	Elsevier 2015-02-01
Series:	Pediatrics and Neonatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1875957214001934
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply: Pulmonary Hemorrhage in Very-low-birth-weight Infants
by: Ting-An Yen, et al.
Published: (2014-08-01)

Adsorption and Co-Adsorption of Polyaldehyde Dextran Nanoparticles and Nonionic Surfactant at an Air–Water Interface: Potential Implications for Pulmonary Drug Delivery
by: Jabłczyńska Katarzyna, et al.
Published: (2017-03-01)

Pulmonary surfactant system
by: Zafer Durgun, et al.

Poly(Vinyl Alcohol) Drug and PVA–Drug–Surfactant Complex Organogel with Dimethyl Sulfoxide as a Drug Delivery System
by: Sabina Otarbayeva, et al.
Published: (2024-11-01)

Comparative efficacy and safety of pulmonary surfactant delivery strategies in neonatal RDS: a network meta-analysis
by: Shiyue Liu, et al.
Published: (2024-12-01)

Optimization of the Proportion of Surfactant, Co-Surfactant, and Candlenut Oil for Self-Nanoemulsifying Drug Delivery System (SNEDDS) of Secang Heartwood (Caesalpinia sappan L.) Methanolic Extract
by: Anif Nur Artanti, et al.
Published: (2021-03-01)

Maternal Stress During Gestation: Birth Outcomes and the Stress-related Hormone Response of Neonates
by: Chien-Yu Huang, et al.
Published: (2016-12-01)

Effects of Breast Milk and Vanilla Odors on Premature Neonates’ Heart Rate and Blood Oxygen Saturation During and After Venipuncture
by: Yu-Chien Wei, et al.
Published: (2016-12-01)

Predictors of outcome in neonatal hypoxic ischemic encephalopathy after therapeutic hypothermia
by: Yu-Jung Lin, et al.
Published: (2017-12-01)

The optimal inserted length of percutaneous central venous catheters on neonates
by: Hsin-Chung Huang, et al.
Published: (2020-04-01)

211 G to A variation of UGT1A1 and severe neonatal hyperbilirubinemia
by: Yu-Jung Lin, et al.
Published: (2018-02-01)

Protect the Unprotected: Neonatal Sepsis in Very-Low-Birth-Weight Infants
by: Chun-Yi Lu, et al.
Published: (2012-08-01)

Pulmonary Surfactant Preparations and Surfactant Therapy for ARDS in Surgical Intensive Care (a Literature Review)
by: O. A. Rosenberg
Published: (2019-04-01)

Surfactants and Polymeric Micelles: Innovations in Transdermal and Topical Cosmeceutical Delivery
by: Dudhat Kiran, et al.
Published: (2025-01-01)

Short-term Outcome of Pulmonary Hemorrhage in Very-Low-Birth-Weight Preterm Infants
by: Ting-An Yen, et al.
Published: (2013-10-01)

Changes in the pulmonary surfactant in patients with mild to moderate COVID-19
by: Spela Kokelj, et al.
Published: (2025-01-01)

Pulmonary Surfactants for Acute and Chronic Lung Diseases (Part II)
by: O. A. Rozenberg
Published: (2014-10-01)

Pulmonary Surfactants for Acute and Chronic Lung Diseases (Part I)
by: O. A. Rozenberg
Published: (2014-08-01)

Changes in the pulmonary surfactant in patients with mild to moderate COVID-19.
by: Spela Kokelj, et al.
Published: (2025-01-01)

Immunohistochemical evaluation of surfactant-associated protein in fibrosis-cavernous pulmonary tuberculosis
by: E. P. Golubinskaya, et al.
Published: (2019-12-01)

Effects of Nicotine on the Thermodynamics and Phase Coexistence of Pulmonary Surfactant Model Membranes
by: Fadi S. S. Magalhães, et al.
Published: (2024-12-01)

Targeted Drug Delivery System for Pulmonary Fibrosis: Design and Development of Biomaterials
by: Jinsha Liu, et al.
Published: (2025-04-01)

Surfactant-Enabled Nanocarriers in Breast Cancer Therapy: Targeted Delivery and Multidrug Resistance Reversal
by: Ashirwad Jadhav, et al.
Published: (2025-06-01)

Pulmonary Neuroendocrine Cell Hyperplasia Associated with Surfactant Protein C Gene Mutation
by: Norlalak Jiramethee, et al.
Published: (2017-01-01)

Drug Delivery Systems for Respiratory Diseases: Insights into the Therapeutic Innovations for Pulmonary Administration
by: Mershen Govender, et al.
Published: (2025-04-01)

Extreme prematurity-associated alterations of pulmonary inflammatory mediators before and after surfactant administration
by: Rajeev Mehta, et al.
Published: (2023-03-01)

Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer
by: Raquel Fernández-García, et al.
Published: (2024-12-01)

Evaporation Dynamics and Dosimetry Methods in Numerically Assessing MDI Performance in Pulmonary Drug Delivery
by: Mohamed Talaat, et al.
Published: (2024-12-01)

Tailoring Fumaric Acid Delivery: The Role of Surfactant-Enhanced Solid Lipid Microparticles via Spray-Congealing
by: Yen-Chiu Tsai, et al.
Published: (2024-10-01)

Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement
by: Sunil Kamboj, et al.
Published: (2014-01-01)

Characterization of atomization and delivery efficiency of exogenous surfactant in preterm infant lungs using an ex vivo respiratory model
by: Ghalia Kaouane, et al.
Published: (2025-05-01)

Optimizing Photosensitizer Delivery for Effective Photodynamic Inactivation of <i>Klebsiella pneumoniae</i> Under Lung Surfactant Conditions
by: Fernanda Alves, et al.
Published: (2025-06-01)

Breathing new life nanomedicines for pulmonary drug delivery: targeting approaches, experimental models, and regulatory aspects
by: Amol Gholap, et al.
Published: (2025-06-01)

The pristine unused pulmonary surfactant isolated from human amniotic fluid forms highly condensed interfacial films
by: Jose Carlos Castillo‐Sánchez, et al.
Published: (2025-06-01)

Surfactant Protein-D, Fibrinogen, and Interleukin-6 Correlation with Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease
by: Anum Wahid, et al.
Published: (2025-07-01)

Surfactant Protein-D, Fibrinogen, and Interleukin-6 Correlation with Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease
by: Anum Wahid, et al.
Published: (2025-07-01)

Comment on “the efficacy of lung ultrasound scores-directed pulmonary surfactant treatment in preterm infants with respiratory distress syndrome”
by: Ling Zeng, et al.
Published: (2025-12-01)

Possibilities of Adding Pulmonary Surfactant to Comprehensive Therapy of Patients with Respiratory Tuberculosis: Results of a Prospective Comparative Study
by: Yu. I. Timakova, et al.
Published: (2024-10-01)

Relationship between gene polymorphisms of pulmonary alveolar surfactant protein D and genetic susceptibility in elderly Han patients with chronic obstructive pulmonary disease in Sichuan
by: Shi Fangyu, et al.
Published: (2025-07-01)

BINDING ISOTHERMS SURFACTANT-PROTEINS
by: Elena Irina Moater, et al.
Published: (2011-12-01)